期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 較慢,6-12周

The Journal of Chemotherapy is an international multidisciplinary journal committed to the rapid publication of high quality, peer-reviewed, original research on all aspects of antimicrobial and antitumor chemotherapy.

The Journal publishes original experimental and clinical research articles, state-of-the-art reviews, brief communications and letters on all aspects of chemotherapy, providing coverage of the pathogenesis, diagnosis, treatment, and control of infection, as well as the use of anticancer and immunomodulating drugs.

Specific areas of focus include, but are not limited to:

· Antibacterial, antiviral, antifungal, antiparasitic, and antiprotozoal agents;

· Anticancer classical and targeted chemotherapeutic agents, biological agents, hormonal drugs, immunomodulatory drugs, cell therapy and gene therapy;

· Pharmacokinetic and pharmacodynamic properties of antimicrobial and anticancer agents;

· The efficacy, safety and toxicology profiles of antimicrobial and anticancer drugs;

· Drug interactions in single or combined applications;

· Drug resistance to antimicrobial and anticancer drugs;

· Research and development of novel antimicrobial and anticancer drugs, including preclinical, translational and clinical research;

· Biomarkers of sensitivity and/or resistance for antimicrobial and anticancer drugs;

· Pharmacogenetics and pharmacogenomics;

· Precision medicine in infectious disease therapy and in cancer therapy;

· Pharmacoeconomics of antimicrobial and anticancer therapies and the implications to patients, health services, and the pharmaceutical industry.

《化學(xué)治療雜志》是一本國(guó)際多學(xué)科雜志，致力于快速發(fā)表高質(zhì)量、同行評(píng)審的原創(chuàng)研究，涵蓋抗菌和抗腫瘤化學(xué)治療的各個(gè)方面。

該雜志發(fā)表原創(chuàng)實(shí)驗(yàn)和臨床研究文章、最新評(píng)論、簡(jiǎn)短通訊和化學(xué)治療各個(gè)方面的信件，涵蓋感染的發(fā)病機(jī)制、診斷、治療和控制，以及抗癌和免疫調(diào)節(jié)藥物的使用。

具體重點(diǎn)領(lǐng)域包括但不限于：

· 抗菌、抗病毒、抗真菌、抗寄生蟲(chóng)和抗原蟲(chóng)藥物；

· 抗癌經(jīng)典和靶向化學(xué)治療劑、生物制劑、激素藥物、免疫調(diào)節(jié)藥物、細(xì)胞治療和基因治療；

· 抗菌和抗癌藥物的藥代動(dòng)力學(xué)和藥效學(xué)特性；

·抗菌和抗癌藥物的功效、安全性和毒理學(xué)概況；

· 單一或聯(lián)合應(yīng)用中的藥物相互作用；

· 抗菌和抗癌藥物的耐藥性；

· 新型抗菌和抗癌藥物的研究和開(kāi)發(fā)，包括臨床前、轉(zhuǎn)化和臨床研究；

· 抗菌和抗癌藥物敏感性和/或耐藥性的生物標(biāo)志物；

· 藥物遺傳學(xué)和藥物基因組學(xué)；

· 傳染病治療和癌癥治療中的精準(zhǔn)醫(yī)療；

· 抗菌和抗癌療法的藥物經(jīng)濟(jì)學(xué)及其對(duì)患者、衛(wèi)生服務(wù)和制藥行業(yè)的影響。

《Journal Of Chemotherapy》(化療雜志)編輯部通訊方式為ESIFT SRL, VIA CARLO DEL GRECO 36,, FLORENCE, ITALY, 50141。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢(xún)我們的客服老師。我們專(zhuān)注于期刊咨詢(xún)服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。